Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Update on rotavirus vaccine underperformance in low- to middle-income countries and next-generation vaccines
Benjamin Lee
Human Vaccines & Immunotherapeutics (2020) Vol. 17, Iss. 6, pp. 1787-1802
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape
Natalie I Mazur, Jonne Terstappen, Ranju Baral, et al.
The Lancet Infectious Diseases (2022) Vol. 23, Iss. 1, pp. e2-e21
Open Access | Times Cited: 280
Aetiology and incidence of diarrhoea requiring hospitalisation in children under 5 years of age in 28 low-income and middle-income countries: findings from the Global Pediatric Diarrhea Surveillance network
Adam L. Cohen, James A Platts-Mills, Tomoka Nakamura, et al.
BMJ Global Health (2022) Vol. 7, Iss. 9, pp. e009548-e009548
Open Access | Times Cited: 94
Rotaviruses: From Pathogenesis to Disease Control—A Critical Review
Cornelius Arome Omatola, Ademola O. Olaniran
Viruses (2022) Vol. 14, Iss. 5, pp. 875-875
Open Access | Times Cited: 61
Understanding Rotavirus Vaccine Efficacy and Effectiveness in Countries with High Child Mortality
Tintu Varghese, Gagandeep Kang, A. Duncan Steele
Vaccines (2022) Vol. 10, Iss. 3, pp. 346-346
Open Access | Times Cited: 59
Rotavirus in developing countries: molecular diversity, epidemiological insights, and strategies for effective vaccination
Asma Sadiq, Jadoon Khan
Frontiers in Microbiology (2024) Vol. 14
Open Access | Times Cited: 13
Temporal changes in the positivity rate of common enteric viruses among paediatric admissions in coastal Kenya, during the COVID-19 pandemic, 2019–2022
Arnold W. Lambisia, Nickson Murunga, Martin Mutunga, et al.
Gut Pathogens (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 6
Rotavirus research: 2014–2020
Sarah Caddy, Guido Papa, Alexander Borodavka, et al.
Virus Research (2021) Vol. 304, pp. 198499-198499
Closed Access | Times Cited: 40
mRNA-based VP8* nanoparticle vaccines against rotavirus are highly immunogenic in rodents
Sandro Roier, Vidya Mangala Prasad, Monica McNeal, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 15
Correlates of immune protection against human rotaviruses: natural infection and vaccination
Tayebeh Latifi, Atefeh Kachooei, Somayeh Jalilvand, et al.
Archives of Virology (2024) Vol. 169, Iss. 3
Closed Access | Times Cited: 5
Geographic disparities impacting oral vaccine performance: Observations and future directions
Rachel M. Burke, Sasirekha Ramani, Julia Lynch, et al.
Clinical & Experimental Immunology (2025)
Closed Access
Diet, microbiome, and probiotics establish a crucial link in vaccine efficacy
Soumam Dutta, Niloy Chatterjee, Nicholas L. F. Gallina, et al.
Critical Reviews in Microbiology (2025), pp. 1-26
Open Access
A retrospective study using machine learning to develop predictive model to identify rotavirus-associated acute gastroenteritis in children
Sourav Paul, Minhazur Rahman, Anutee Dolley, et al.
PeerJ (2025) Vol. 13, pp. e19025-e19025
Open Access
Potential impact and cost-effectiveness of injectable next-generation rotavirus vaccines in 137 LMICs: a modelling study
Frédéric Debellut, Clint Pecenka, William P. Hausdorff, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 1
Open Access | Times Cited: 16
Impact of rotavirus vaccination in Malawi from 2012 to 2022 compared to model predictions
Virginia E. Pitzer, Latif Ndeketa, Ernest O. Asare, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 3
The Full Impact of Rotavirus Vaccines in Africa Has Yet to Be Realized
A. Duncan Steele, George Armah, Jason M. Mwenda, et al.
Clinical Infectious Diseases (2023) Vol. 76, Iss. Supplement_1, pp. S1-S4
Open Access | Times Cited: 8
Rotavirus-Specific Maternal Serum Antibodies and Vaccine Responses to RV3-BB Rotavirus Vaccine Administered in a Neonatal or Infant Schedule in Malawi
Benjamin Morgan, Eleanor A Lyons, Amanda Handley, et al.
Viruses (2024) Vol. 16, Iss. 9, pp. 1488-1488
Open Access | Times Cited: 2
Insights into Recent Advancements in Human and Animal Rotavirus Vaccines: Exploring New Frontiers
Ahmed H. Ghonaim, Sherin R. Rouby, Wedad M. Nageeb, et al.
Virologica Sinica (2024)
Open Access | Times Cited: 2
Current Update on Rotavirus in-Silico Multiepitope Vaccine Design
Pooja Rani Kuri, Pranab Goswami
ACS Omega (2022) Vol. 8, Iss. 1, pp. 190-207
Open Access | Times Cited: 12
T-Cell Responses after Rotavirus Infection or Vaccination in Children: A Systematic Review
Natasha Makabilo Laban, Martin R. Goodier, Samuel Bosomprah, et al.
Viruses (2022) Vol. 14, Iss. 3, pp. 459-459
Open Access | Times Cited: 11
Effects of milk extracellular vesicles from bovine, human, and caprine origin on rotavirus infectivity in cultured human intestinal cells
Caroline Vangsøe, Dimitra Graikini, Anni Bojsen, et al.
International Dairy Journal (2024) Vol. 154, pp. 105937-105937
Closed Access | Times Cited: 2
Evaluation of ROTARIX® Booster Dose Vaccination at 9 Months for Safety and Enhanced Anti-Rotavirus Immunity in Zambian Children: A Randomised Controlled Trial
Natasha Makabilo Laban, Samuel Bosomprah, Michelo Simuyandi, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 346-346
Open Access | Times Cited: 5
The impact of rotavirus vaccination on acute diarrhea in Thai children under 5 years of age in the first year of universal implementation of rotavirus vaccines in the National Immunization Program (NIP) in Thailand: a 6-year analysis
Busara Charoenwat, Kunanya Suwannaying, Watuhatai Paibool, et al.
BMC Public Health (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Does Anybody Want an Injectable Rotavirus Vaccine, and Why? Understanding the Public Health Value Proposition of Next-Generation Rotavirus Vaccines
William P. Hausdorff, Jessica Price, Frédéric Debellut, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 149-149
Open Access | Times Cited: 8
Novel mRNA-based VP8* vaccines against rotavirus are highly immunogenic in rodents
Sandro Roier, Vidya Mangala Prasad, Monica McNeal, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Oral rotavirus vaccine shedding as a marker of mucosal immunity
Benjamin Lee, Md. Abdul Kader, E. Ross Colgate, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top